| European Case Law Identifier: | ECLI:EP:BA:2016:T102011.20160407 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 07 April 2016 | ||||||||
| Case number: | T 1020/11 | ||||||||
| Application number: | 06848471.6 | ||||||||
| IPC class: | A61K 39/295 A61K 39/04 A61K 39/12 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Multivalent PCV2 immunogenic compositions and methods of producing such compositions | ||||||||
| Applicant name: | Boehringer Ingelheim Vetmedica, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request Amendments - allowable (yes) Sufficiency of disclosure - (yes) Claims - clarity (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111020eu1.html
Date retrieved: 17 May 2021